Actively Recruiting
OCTA in Cardiovascular Disease and Healthy Controls
Led by University of Erlangen-Nürnberg Medical School · Updated on 2026-01-22
64
Participants Needed
1
Research Sites
65 weeks
Total Duration
On this page
Sponsors
U
University of Erlangen-Nürnberg Medical School
Lead Sponsor
G
German Diabetes Association
Collaborating Sponsor
AI-Summary
What this Trial Is About
This prospective clinical study will involve the non-invasive assessment of retinal vessels using OCTA (Cirrus OCT 6000 AngioPlex) and scanning laser Doppler flowmetry (SLDF) in patients with cardiovascular disease and healthy individuals. The study will be conducted at the Clinical Research Centre (CRC), Department of Nephrology and Hypertension at the University of Erlangen-Nuremberg.
CONDITIONS
Official Title
OCTA in Cardiovascular Disease and Healthy Controls
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Cardiovascular disease defined as one or more of arterial hypertension, type 2 diabetes mellitus, chronic kidney disease, or heart failure
- Body mass index (BMI) between 18 and 29.9 kg/m2 for healthy individuals
- Non-smoker status for healthy individuals
- Good general health based on medical assessments, vital signs, physical exam, and lab tests
You will not qualify if you...
- Active ophthalmological (retinal) disease impairing retinal vessel assessment (e.g. glaucoma, cataracts, retinal oedema)
- Clinically relevant abnormalities in physical exam, vital signs, or lab results for healthy individuals
- History of cardiovascular disease or other significant medical conditions for healthy individuals
- Blood pressure at or above 140/90 mmHg
- Heart rate outside 50-99 bpm
- Regular use of cardiovascular medications within one month before inclusion
- Alcohol or drug abuse
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Erlangen Nuremberg
Erlangen, Bavaria, Germany, 91054
Actively Recruiting
Research Team
A
Agnes Bosch, MD
CONTACT
D
Dennis Kannenkeril, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here